11c dasb
Small moleculeexperimentalImaging agent
Clinical trial activity
4 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
2
Earliest trial started May 1, 2011 (NCT02020408)
Timeline
Indications
Approved for
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 11--carbon
Oral
No
Parenteral
No
Topical
No
Also known as
- 11cdasb
- 11c dasb
- 11c dasb
- dasb
- dasb
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03581305 | Phase 1 | Nov 20, 2018 | National Institutes of Health (NIH) |
| NCT02717052 | Phase 2 | May 1, 2016 | University of Vienna |
| NCT02711215 | Phase 4 | May 1, 2015 | University of Vienna |
| NCT02020408 | Phase 4 | May 1, 2011 | National Institute of Mental Health (NIMH), University of California, San Diego |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Vienna | Academic/Hospital | 2 | 2 | 2 | 2015 |
| National Institute of Mental Health (NIMH) | Government | 1 | 0 | 1 | 2011 |
| National Institutes of Health (NIH) | Government | 1 | 1 | 1 | 2018 |
| University of California, San Diego | Academic/Hospital | 1 | 1 | 1 | 2011 |
4 organizations
Page 1 / 1